Concepedia

Viktoria Marquardt

VM

Statistics

Publications

12

Citations

485

H-Index

11

Active since

2015

Affiliations

Heinrich Heine University Düsseldorf(Current)

German Cancer Research Center

Düsseldorf University Hospital

Heidelberg University

Deutsches Konsortium für Translationale Krebsforschung

Viktoria Marquardt is an author at Heinrich Heine University Düsseldorf specializing in molecular oncology, oncology, and medicine.

Publications per year

2015–2023

12

Publications

12

Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response

Sanil Bhatia, Daniela Diedrich, Benedikt Frieg et al. · Blood · 2018 · 79 citations · Full text

, , +6

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation

Viktoria Marquardt, Johanna Theruvath, David Pauck et al. · Journal for ImmunoTherapy of Cancer · 2023 · 60 citations · Full text

, , +17

The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

Ulvi Ahmadov, Daniel Picard, Jasmin Bartl et al. · Cell Death and Disease · 2021 · 54 citations · Full text

, , +17

Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing

Florian Selt, Juliane Hohloch, Thomas Hielscher et al. · Oncotarget · 2016 · 53 citations · Full text

, , +17

Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines

Katharina Stenzel, Alexandra Hamacher, Finn K. Hansen et al. · Journal of Medicinal Chemistry · 2017 · 49 citations · Full text

, , +14

1–5 of 12